BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15345470)

  • 21. Micro- and macrovesicular steatotic liver model for transplantation induced by ethanol and protein-deficient diet.
    Spannbauer MM; Oleszczuk A; Tannapfel A; Blüher M; Pietsch UC; Hengstler J; Donaubauer B; Madaj-Sterba P; Fürll M; Schuhmacher A; Thiery J; Hauss JP; Schön MR
    Transplant Proc; 2005; 37(1):210-1. PubMed ID: 15808596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
    Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in hepatic glucagon receptor density and in Gsalpha and Gialpha2 protein content with diet-induced hepatic steatosis: effects of acute exercise.
    Charbonneau A; Melancon A; Lavoie C; Lavoie JM
    Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E8-14. PubMed ID: 15687107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe liver steatosis correlates with nitrosative and oxidative stress in rats.
    Grattagliano I; Caraceni P; Calamita G; Ferri D; Gargano I; Palasciano G; Portincasa P
    Eur J Clin Invest; 2008 Jul; 38(7):523-30. PubMed ID: 18578693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
    Zheng LY; Pan JQ; Lv JH
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A voluntary oral ethanol-feeding rat model associated with necroinflammatory liver injury.
    Tipoe GL; Liong EC; Casey CA; Donohue TM; Eagon PK; So H; Leung TM; Fogt F; Nanji AA
    Alcohol Clin Exp Res; 2008 Apr; 32(4):669-82. PubMed ID: 18341647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver lipid metabolism.
    Nguyen P; Leray V; Diez M; Serisier S; Le Bloc'h J; Siliart B; Dumon H
    J Anim Physiol Anim Nutr (Berl); 2008 Jun; 92(3):272-83. PubMed ID: 18477307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NF-kappaBp65/mTOR-dependent mechanism.
    Vinciguerra M; Veyrat-Durebex C; Moukil MA; Rubbia-Brandt L; Rohner-Jeanrenaud F; Foti M
    Gastroenterology; 2008 Jan; 134(1):268-80. PubMed ID: 18166358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thioacetamide-induced hepatic damage in a rat nutritional model of steatohepatitis.
    Avni Y; Shirin H; Aeed H; Matas Z; Shahmurov M; Birkenfeld S; Bruck R
    J Med; 2003; 34(1-6):121-37. PubMed ID: 17682318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety limit of the extent of hepatectomy for rats with moderately fatty liver: experimental study concerning living liver donor safety.
    Morioka D; Watanabe K; Makino H; Saito S; Ueda M; Kubota T; Sekido H; Matsuo K; Ichikawa Y; Endo I; Togo S; Shimada H
    J Gastroenterol Hepatol; 2006 Feb; 21(2):367-73. PubMed ID: 16509860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of nitric oxide in the modulation of hepatic microcirculation and tissue oxygenation in an experimental model of hepatic steatosis.
    Ijaz S; Yang W; Winslet MC; Seifalian AM
    Microvasc Res; 2005 Nov; 70(3):129-36. PubMed ID: 16203017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A human hepatocellular in vitro model to investigate steatosis.
    Gómez-Lechón MJ; Donato MT; Martínez-Romero A; Jiménez N; Castell JV; O'Connor JE
    Chem Biol Interact; 2007 Jan; 165(2):106-16. PubMed ID: 17188672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indication for a specific interaction of fatty acids with a liver sinusoidal plasma membrane carrier.
    Stremmel W; Gunnawan J
    Eur J Med Res; 1998 Feb; 3(1-2):71-6. PubMed ID: 9512971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Facilitated dissociation of albumin-fatty acid complexes by rat hepatocytes.
    Burczynski FJ; Moran JB; Cai ZS
    J Pharmacol Exp Ther; 1993 Nov; 267(2):714-9. PubMed ID: 8246146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocyte [3H]-palmitate uptake: effect of albumin surface charge modification.
    Burczynski FJ; Wang GQ; Elmadhoun B; She YM; Roberts MS; Standing KG
    Can J Physiol Pharmacol; 2001 Oct; 79(10):868-75. PubMed ID: 11697746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the cellular transmembrane electrical potential difference on the hepatic uptake of palmitate.
    Burczynski FJ; Hung D; Wang GQ; Elmadhoun B; Lewis A; Chang P; Rajaraman G; Robert S
    Mol Cell Biochem; 2005 Feb; 270(1-2):115-24. PubMed ID: 15792360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disposition kinetics of propranolol isomers in the perfused rat liver.
    Hung DY; Siebert GA; Chang P; Anissimov YG; Roberts MS
    J Pharmacol Exp Ther; 2004 Nov; 311(2):822-9. PubMed ID: 15192084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The physical-chemical basis for sex-related differences in uptake of fatty acids by the liver.
    Noy N; Donnelly TM; Cooper RB; Zakim D
    Biochim Biophys Acta; 1989 Jun; 1003(2):125-30. PubMed ID: 2730886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of albumin on palmitate transport in the isolated perfused rat liver.
    Ferraresi-Filho O; Ferraresi ML; Constantin J; Ishii-Iwamoto EL; Schwab AJ; Bracht A
    Braz J Med Biol Res; 1989; 22(1):139-43. PubMed ID: 2667668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uptake of labeled palmitate by the intact liver: role of intracellular binding sites.
    Goresky CA; Daly DS; Mishkin S; Arias IM
    Am J Physiol; 1978 Jun; 234(6):E542-53. PubMed ID: 665758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.